 | • レポートコード：MRC2-11QY12308 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫レパートリーシーケンスのグローバル市場について調査・分析したレポートです。種類別（パイロシーケンシング、色素終結シーケンシング、半導体シーケンシング、その他）市場規模、用途別（バイオマーカー発見、感染症、ワクチン開発・有効性、癌免疫療法、自己免疫疾患、移植片拒絶反応・耐性、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫レパートリーシーケンスの競争状況、市場シェア ・世界の免疫レパートリーシーケンス市場：種類別市場規模 2015年-2020年（パイロシーケンシング、色素終結シーケンシング、半導体シーケンシング、その他） ・世界の免疫レパートリーシーケンス市場：種類別市場規模予測 2021年-2026年（パイロシーケンシング、色素終結シーケンシング、半導体シーケンシング、その他） ・世界の免疫レパートリーシーケンス市場：用途別市場規模 2015年-2020年（バイオマーカー発見、感染症、ワクチン開発・有効性、癌免疫療法、自己免疫疾患、移植片拒絶反応・耐性、その他） ・世界の免疫レパートリーシーケンス市場：用途別市場規模予測 2021年-2026年（バイオマーカー発見、感染症、ワクチン開発・有効性、癌免疫療法、自己免疫疾患、移植片拒絶反応・耐性、その他） ・北米の免疫レパートリーシーケンス市場分析：米国、カナダ ・ヨーロッパの免疫レパートリーシーケンス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫レパートリーシーケンス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫レパートリーシーケンス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫レパートリーシーケンス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ArcherDX、Junom Therapeutics、Roche Holding、Illumina、ThermoFisher Scietific、Pacific Biosciences、CD Genomics、Atreca、Adaptive Biotechnologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
Market Analysis and Insights: Global Immune Repertoire Sequencing Market
The global Immune Repertoire Sequencing market size is projected to reach US$ 106.8 million by 2026, from US$ 103.3 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Immune Repertoire Sequencing Scope and Market Size
Immune Repertoire Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immune Repertoire Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
ArcherDX
Junom Therapeutics
Roche Holding
Illumina
ThermoFisher Scietific
Pacific Biosciences
CD Genomics
Atreca
Adaptive Biotechnologies
Market segment by Type, the product can be split into
Pyro-Sequencing
Dye-Terminating Sequencing
Semiconductor Sequencing
Others
Market segment by Application, split into
Biomarker Discovery
Infectious Diseases
Vaccine Development and Efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant Rejection and Tolerance
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
1.4 Market by Type
1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pyro-Sequencing
1.4.3 Dye-Terminating Sequencing
1.4.4 Semiconductor Sequencing
1.4.5 Others
1.5 Market by Application
1.5.1 Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2026
1.5.2 Biomarker Discovery
1.5.3 Infectious Diseases
1.5.4 Vaccine Development and Efficacy
1.5.5 Cancer Immunotherapy
1.5.6 Autoimmune Disease
1.5.7 Transplant Rejection and Tolerance
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Immune Repertoire Sequencing Market Perspective (2015-2026)
2.2 Global Immune Repertoire Sequencing Growth Trends by Regions
2.2.1 Immune Repertoire Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immune Repertoire Sequencing Historic Market Share by Regions (2015-2020)
2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immune Repertoire Sequencing Market Growth Strategy
2.3.6 Primary Interviews with Key Immune Repertoire Sequencing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immune Repertoire Sequencing Players by Market Size
3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2015-2020)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2015-2020)
3.1.3 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immune Repertoire Sequencing Market Concentration Ratio
3.2.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2019
3.3 Immune Repertoire Sequencing Key Players Head office and Area Served
3.4 Key Players Immune Repertoire Sequencing Product Solution and Service
3.5 Date of Enter into Immune Repertoire Sequencing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2015-2020)
4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Immune Repertoire Sequencing Market Size by Application (2015-2020)
5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immune Repertoire Sequencing Market Size (2015-2020)
6.2 Immune Repertoire Sequencing Key Players in North America (2019-2020)
6.3 North America Immune Repertoire Sequencing Market Size by Type (2015-2020)
6.4 North America Immune Repertoire Sequencing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size (2015-2020)
7.2 Immune Repertoire Sequencing Key Players in Europe (2019-2020)
7.3 Europe Immune Repertoire Sequencing Market Size by Type (2015-2020)
7.4 Europe Immune Repertoire Sequencing Market Size by Application (2015-2020)
8 China
8.1 China Immune Repertoire Sequencing Market Size (2015-2020)
8.2 Immune Repertoire Sequencing Key Players in China (2019-2020)
8.3 China Immune Repertoire Sequencing Market Size by Type (2015-2020)
8.4 China Immune Repertoire Sequencing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immune Repertoire Sequencing Market Size (2015-2020)
9.2 Immune Repertoire Sequencing Key Players in Japan (2019-2020)
9.3 Japan Immune Repertoire Sequencing Market Size by Type (2015-2020)
9.4 Japan Immune Repertoire Sequencing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immune Repertoire Sequencing Market Size (2015-2020)
10.2 Immune Repertoire Sequencing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type (2015-2020)
10.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application (2015-2020)
11 India
11.1 India Immune Repertoire Sequencing Market Size (2015-2020)
11.2 Immune Repertoire Sequencing Key Players in India (2019-2020)
11.3 India Immune Repertoire Sequencing Market Size by Type (2015-2020)
11.4 India Immune Repertoire Sequencing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immune Repertoire Sequencing Market Size (2015-2020)
12.2 Immune Repertoire Sequencing Key Players in Central & South America (2019-2020)
12.3 Central & South America Immune Repertoire Sequencing Market Size by Type (2015-2020)
12.4 Central & South America Immune Repertoire Sequencing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 ArcherDX
13.1.1 ArcherDX Company Details
13.1.2 ArcherDX Business Overview
13.1.3 ArcherDX Immune Repertoire Sequencing Introduction
13.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2015-2020))
13.1.5 ArcherDX Recent Development
13.2 Junom Therapeutics
13.2.1 Junom Therapeutics Company Details
13.2.2 Junom Therapeutics Business Overview
13.2.3 Junom Therapeutics Immune Repertoire Sequencing Introduction
13.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.2.5 Junom Therapeutics Recent Development
13.3 Roche Holding
13.3.1 Roche Holding Company Details
13.3.2 Roche Holding Business Overview
13.3.3 Roche Holding Immune Repertoire Sequencing Introduction
13.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.3.5 Roche Holding Recent Development
13.4 Illumina
13.4.1 Illumina Company Details
13.4.2 Illumina Business Overview
13.4.3 Illumina Immune Repertoire Sequencing Introduction
13.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.4.5 Illumina Recent Development
13.5 ThermoFisher Scietific
13.5.1 ThermoFisher Scietific Company Details
13.5.2 ThermoFisher Scietific Business Overview
13.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
13.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.5.5 ThermoFisher Scietific Recent Development
13.6 Pacific Biosciences
13.6.1 Pacific Biosciences Company Details
13.6.2 Pacific Biosciences Business Overview
13.6.3 Pacific Biosciences Immune Repertoire Sequencing Introduction
13.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.6.5 Pacific Biosciences Recent Development
13.7 CD Genomics
13.7.1 CD Genomics Company Details
13.7.2 CD Genomics Business Overview
13.7.3 CD Genomics Immune Repertoire Sequencing Introduction
13.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.7.5 CD Genomics Recent Development
13.8 Atreca
13.8.1 Atreca Company Details
13.8.2 Atreca Business Overview
13.8.3 Atreca Immune Repertoire Sequencing Introduction
13.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.8.5 Atreca Recent Development
13.9 Adaptive Biotechnologies
13.9.1 Adaptive Biotechnologies Company Details
13.9.2 Adaptive Biotechnologies Business Overview
13.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Introduction
13.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2015-2020)
13.9.5 Adaptive Biotechnologies Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Immune Repertoire Sequencing Key Market Segments
Table 2. Key Players Covered: Ranking by Immune Repertoire Sequencing Revenue
Table 3. Ranking of Global Top Immune Repertoire Sequencing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immune Repertoire Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pyro-Sequencing
Table 6. Key Players of Dye-Terminating Sequencing
Table 7. Key Players of Semiconductor Sequencing
Table 8. Key Players of Others
Table 9. Global Immune Repertoire Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Immune Repertoire Sequencing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Immune Repertoire Sequencing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Immune Repertoire Sequencing Market Share by Regions (2015-2020)
Table 13. Global Immune Repertoire Sequencing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Immune Repertoire Sequencing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Immune Repertoire Sequencing Market Growth Strategy
Table 19. Main Points Interviewed from Key Immune Repertoire Sequencing Players
Table 20. Global Immune Repertoire Sequencing Revenue by Players (2015-2020) (Million US$)
Table 21. Global Immune Repertoire Sequencing Market Share by Players (2015-2020)
Table 22. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2019)
Table 23. Global Immune Repertoire Sequencing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Immune Repertoire Sequencing Product Solution and Service
Table 26. Date of Enter into Immune Repertoire Sequencing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 29. Global Immune Repertoire Sequencing Market Size Share by Type (2015-2020)
Table 30. Global Immune Repertoire Sequencing Revenue Market Share by Type (2021-2026)
Table 31. Global Immune Repertoire Sequencing Market Size Share by Application (2015-2020)
Table 32. Global Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 33. Global Immune Repertoire Sequencing Market Size Share by Application (2021-2026)
Table 34. North America Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 36. North America Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 37. North America Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 38. North America Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 39. North America Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 40. Europe Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 42. Europe Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 44. Europe Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 46. China Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 47. China Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 48. China Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 49. China Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 50. China Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 51. China Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 52. Japan Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 54. Japan Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 56. Japan Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 60. Southeast Asia Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 62. Southeast Asia Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 64. India Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 65. India Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 66. India Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 67. India Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 68. India Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 69. India Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Immune Repertoire Sequencing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Immune Repertoire Sequencing Market Share (2019-2020)
Table 72. Central & South America Immune Repertoire Sequencing Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Immune Repertoire Sequencing Market Share by Type (2015-2020)
Table 74. Central & South America Immune Repertoire Sequencing Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Immune Repertoire Sequencing Market Share by Application (2015-2020)
Table 76. ArcherDX Company Details
Table 77. ArcherDX Business Overview
Table 78. ArcherDX Product
Table 79. ArcherDX Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 80. ArcherDX Recent Development
Table 81. Junom Therapeutics Company Details
Table 82. Junom Therapeutics Business Overview
Table 83. Junom Therapeutics Product
Table 84. Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 85. Junom Therapeutics Recent Development
Table 86. Roche Holding Company Details
Table 87. Roche Holding Business Overview
Table 88. Roche Holding Product
Table 89. Roche Holding Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 90. Roche Holding Recent Development
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Product
Table 94. Illumina Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 95. Illumina Recent Development
Table 96. ThermoFisher Scietific Company Details
Table 97. ThermoFisher Scietific Business Overview
Table 98. ThermoFisher Scietific Product
Table 99. ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 100. ThermoFisher Scietific Recent Development
Table 101. Pacific Biosciences Company Details
Table 102. Pacific Biosciences Business Overview
Table 103. Pacific Biosciences Product
Table 104. Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 105. Pacific Biosciences Recent Development
Table 106. CD Genomics Company Details
Table 107. CD Genomics Business Overview
Table 108. CD Genomics Product
Table 109. CD Genomics Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 110. CD Genomics Recent Development
Table 111. Atreca Business Overview
Table 112. Atreca Product
Table 113. Atreca Company Details
Table 114. Atreca Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 115. Atreca Recent Development
Table 116. Adaptive Biotechnologies Company Details
Table 117. Adaptive Biotechnologies Business Overview
Table 118. Adaptive Biotechnologies Product
Table 119. Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2015-2020) (Million US$)
Table 120. Adaptive Biotechnologies Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Repertoire Sequencing Market Share by Type: 2020 VS 2026
Figure 2. Pyro-Sequencing Features
Figure 3. Dye-Terminating Sequencing Features
Figure 4. Semiconductor Sequencing Features
Figure 5. Others Features
Figure 6. Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2026
Figure 7. Biomarker Discovery Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Vaccine Development and Efficacy Case Studies
Figure 10. Cancer Immunotherapy Case Studies
Figure 11. Autoimmune Disease Case Studies
Figure 12. Transplant Rejection and Tolerance Case Studies
Figure 13. Others Case Studies
Figure 14. Immune Repertoire Sequencing Report Years Considered
Figure 15. Global Immune Repertoire Sequencing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Immune Repertoire Sequencing Market Share by Regions: 2020 VS 2026
Figure 17. Global Immune Repertoire Sequencing Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Immune Repertoire Sequencing Market Share by Players in 2019
Figure 20. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Immune Repertoire Sequencing Revenue in 2019
Figure 22. North America Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Immune Repertoire Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
メタゲノムシーケンスの世界市場（～2026年） Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investi…- メタゲノミクスシーケンスの世界市場（～2026年） Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community. The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad rang…
- 次世代シーケンシング（NGS）データ分析の世界市場（～2026年） North America is home to several well-established organizations of NGS data analysis. A significant number of NGS research projects are being carried out in Canadian universities, which in turn has resulted into huge demand for NGS data analysis, thereby affecting the revenue growth in the region. N…
- DNAシーケンシング製品の世界市場（～2026年） DNA sequencing is categorized into first-generation, secondand next-generation, and emerging technologies. Emerging DNA sequencing technologies are cost-effective and offer more rapid and accurate results than other generation technologies. These technologies find application in the areas of diagnos…
- 次世代シーケンシング（NGS）の世界市場（～2026年） NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing. The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud compu…